Loading...
Orion Oyj
ORINY•PNK
Healthcare
Drug Manufacturers - General
$40.80
$0.12(0.30%)
Orion Oyj (ORINY) Financial Performance & Income Statement Overview
Review Orion Oyj’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
29.66%
↑ 29.66%
Operating Income Growth
51.55%
↑ 51.55%
Net Income Growth
52.17%
↑ 52.17%
Operating Cash Flow Growth
146.55%
↑ 146.55%
Operating Margin
27.53%
↑ 27.53%
Gross Margin
61.53%
↑ 61.53%
Net Profit Margin
21.88%
↑ 21.88%
ROE
36.99%
↑ 36.99%
ROIC
30.70%
↑ 30.70%
Orion Oyj (ORINY) Income Statement & Financial Overview
Review Orion Oyj's (ORINY) income statement with detailed quarterly and annual figures.
| Metric | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|
| Revenue | $354.60M | $434.40M | $471.30M | $327.60M |
| Cost of Revenue | $152.80M | $167.10M | $151.90M | $139.10M |
| Gross Profit | $201.80M | $267.30M | $319.40M | $188.50M |
| Gross Profit Ratio | $0.57 | $0.62 | $0.68 | $0.58 |
| R&D Expenses | $41.00M | $62.50M | $36.70M | $43.60M |
| SG&A Expenses | $84.30M | $114.90M | $85.80M | $80.20M |
| Operating Expenses | $124.00M | $174.60M | $117.40M | $123.80M |
| Total Costs & Expenses | $276.80M | $341.70M | $269.30M | $262.90M |
| Interest Income | $0.00 | $0.00 | $0.00 | $0.00 |
| Interest Expense | $0.00 | $1.10M | $600000.00 | $800000.00 |
| Depreciation & Amortization | $13.70M | $0.00 | $0.00 | $12.90M |
| EBITDA | $91.50M | $92.80M | $202.00M | $78.60M |
| EBITDA Ratio | $0.26 | $0.21 | $0.43 | $0.24 |
| Operating Income | $77.80M | $92.70M | $202.00M | $64.70M |
| Operating Income Ratio | $0.22 | $0.21 | $0.43 | $0.20 |
| Other Income/Expenses (Net) | -$1.00M | -$1.00M | -$600000.00 | -$700000.00 |
| Income Before Tax | $76.80M | $91.70M | $201.40M | $65.10M |
| Income Before Tax Ratio | $0.22 | $0.21 | $0.43 | $0.20 |
| Income Tax Expense | $15.60M | $18.30M | $40.70M | $13.10M |
| Net Income | $61.30M | $73.40M | $160.80M | $52.00M |
| Net Income Ratio | $0.17 | $0.17 | $0.34 | $0.16 |
| EPS | $0.44 | $0.52 | $1.14 | $0.37 |
| Diluted EPS | $0.44 | $0.52 | $1.14 | $0.37 |
| Weighted Avg Shares Outstanding | $140.55M | $141.15M | $141.05M | $140.50M |
| Weighted Avg Shares Outstanding (Diluted) | $140.56M | $141.15M | $141.05M | $140.50M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan